Brand Name of Bempedoic Acid
Bempedoic acid is marketed under the brand name NEXLETOL® (in the USA) and Nilemdo® (in the EU) as monotherapy. 1
Available Formulations
Bempedoic acid is commercially available in two formulations:
Monotherapy: NEXLETOL® (USA) / Nilemdo® (EU) - contains bempedoic acid 180 mg alone 1, 2
Fixed-dose combination: NEXLIZET® (USA) / Nustendi® (EU) - contains bempedoic acid 180 mg combined with ezetimibe 10 mg 3, 2
Product Details
Each NEXLETOL tablet contains 180 mg of bempedoic acid as a white to off-white, oval, film-coated tablet debossed with "180" on one side and "ESP" on the other side 1. The medication is supplied in bottles of 30 or 90 tablets with child-resistant caps 1.
Both formulations were FDA approved in 2020 and are indicated as adjunct to diet and maximally tolerated statin therapy for adults with heterozygous familial hypercholesterolemia (HeFH) or atherosclerotic cardiovascular disease (ASCVD) who require additional LDL-C lowering 3.